[1] COUTERMARSH-OTT S, EDEN K, ALLEN I C.Beyond the inflammasome:Regulatory NOD-like receptor modulation of the host immune response following virus exposure[J]. Journal General Virology, 2016, 97(4):825-838. [2] VELLOSO F J, TROMBETTA-LIMA M, ANSCHAU V, et al. NOD-like receptors:Major players (and targets) in the interface between innate immunity and cancer[J]. Bioscience Reports, 2019, 39(4):BSR20181709. [3] LUPFER C, KANNEGANTI T D.Unsolved mysteries in NLR biology[J]. Frontiers in Immunology, 2013, 4:285. [4] CHAPUT C, SANDER L E, SUTTORP N, et al. NOD-like receptors in lung diseases[J]. Frontiers in Immunology, 2013, 4:393. [5] HEIM V J, STAFFORD C A, NACHBUR U.NOD signaling and cell death[J]. Frontiers in Cell and Developmental Biology, 2019, 7:208. [6] CONTI B J, DAVIS B K, ZHANG J, et al. CATERPILLER 16.2(CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function[J]. The Journalof Biology Chemistry, 2005, 280(18):18375-18385. [7] SHA Z, ABERNATHY J W, WANG S, et al. NOD-like subfamily of the nucleotide-binding domain and leucine-rich repeat containing family receptors and their expression in channel catfish[J]. Developmental and Comparative Immunology, 2009, 33(9):991-999. [8] PONTIGO J P, YAEZ A, SANCHEZ P, et al. Characterization and expression analysis of NOD-like receptor 3(NLRC3) against infection with Piscirickettsia salmonis in Atlantic salmon[J]. Developmental and Comparative Immunology, 2021, 114:103865. [9] SCHNEIDER M, ZIMMERMANN A G, ROBERTS R A, et al. The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-kappaB[J]. Nature Immunology, 2012, 13(9):823-831. [10] O'BRIEN A D, MELTON A R, SCHMITT C K, et al. Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington[J]. Journal of Clinical Microbiology, 1993, 31(10):2799-2801. [11] GARCÍA A, FOX J G.The rabbit as a new reservoir host of enterohemorrhagic Escherichia coli[J]. Emerging Infectious Diseases, 2003, 9(12):1592-1597. [12] LIVAK K J, SCHMITTGEN T D.Analysis of relative gene expression data using Real-time quantitative PCR and the 2(-delta delta C(t)) method[J]. Methods, 2001, 25(4):402-408. [13] LI Z T, LIU H, ZHANG W Q.NLRC3 alleviates hypoxia/reoxygenation induced inflammation in RAW264.7 cells by inhibiting K63-linked ubiquitination of TRAF6[J]. Hepatobiliary & Pancreatic Diseases Internationa, 2020, 19(5):455-460. [14] PLATNICH J M, MURUVE D A.NOD-like receptors and inflammasomes:A review of their canonical and non-canonical signaling pathways[J]. Archives of Biochemistry and Biophysics, 2019, 670:4-14. [15] 姜合祥, 蔡孜萌, 秦晓冰, 等.水貂Toll样受体5编码区基因的克隆及序列分析[J]. 畜牧与兽医, 2017, 49(12):70-74. JIANG H X, CAI Z M, QIN X B, et al. Molecular cloning and sequence analysis of mink Toll-like receptor 5 gene CDS[J]. Animal Husbandry & Veterinary Medicine, 2017, 49(12):70-74.(in Chinese) [16] WIESE K M, COATES B M, RIDGE K M.The role of nucleotide-binding oligomerization domain-like receptors in pulmonary infection[J]. American Journal of Respiratory Cell and Molecular Biology, 2017, 57(2):151-161. [17] JAKOPIN Z.Nucleotide-binding oligomerization domain (NOD) inhibitors:A rational approach toward inhibition of NOD signaling pathway[J]. Journal of Medicinal Chemistry, 2014, 57(16):6897-6918. [18] PHILPOTT D J, SORBARA M T, ROBERTSON S J, et al. NOD proteins:Regulators of inflammation in health and disease[J]. Nature Reviews Immunology, 2014, 14(1):9-23. [19] BARBE F, DOUGLAS T, SALEH M.Advances in NOD-like receptors (NLR) biology[J]. Cytokine & Growth Factor Reviews, 2014, 25(6):681-697. [20] MAEKAWA S, OHTO U, SHIBATA T, et al. Crystal structure of NOD2 and its implications in human disease[J]. Nature Communications, 2016, 7:11813. [21] WANG X, HARDWIDGE P R.Enterotoxigenic Escherichia coli prevents host NF-kappaB activation by targeting IkappaBalpha polyubiquitination[J]. Infection and Immunity, 2012, 80(12):4417-4425. [22] GULTEKIN Y, EREN E, OZOREN N.Overexpressed NLRC3 acts as an anti-inflammatory cytosolic protein[J]. Journal of Innate Immunity, 2015, 7(1):25-36. [23] YASUKAWA K, KOSHIBA T.Mitochondrial reactive zones in antiviral innate immunity[J]. Biochimica et Biophysica Acta-General Subjects, 2021, 1865(3):129839. [24] TOCKER A M, DUROCHER E, JACOB K D, et al. The scaffolding protein IQGAP1 interacts with NLRC3 and inhibits type Ⅰ IFN production[J]. Journal of Immunology, 2017, 199(8):2896-2909. [25] ZHOU F, ZHAN Q, DING Z, et al. A NLRC3-like gene from blunt snout bream (Megalobrama amblycephala):Molecular characterization, expression and association with resistance to Aeromonas hydrophila infection[J]. Fish & Shellfish Immunology, 2017, 63:213-219. |